DDD affects around 2% of people but has no approved treatment. A new feasibility trial asks whether CBT-f-DDD could change that.
[read the full story...]
DDD affects around 2% of people but has no approved treatment. A new feasibility trial asks whether CBT-f-DDD could change that.
[read the full story...]